Stocktoria
Damora Therapeutics, Inc. DMRA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-10-29
Chart by TradingView
2/9
Piotroski F — financial health
7.04
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$210.9M | -$22.3M | -$39.9M | -$61.2M | -$52.2M |
| Net income | -$209.8M | -$21.4M | -$38.3M | -$61.6M | -$51.8M |
| Operating cash flow | -$6.7M | -$18.6M | -$36.9M | -$42.9M | -$52.3M |
| Free cash flow | — | — | — | -$43.1M | -$52.5M |
| Total assets | $260.5M | $17.1M | $38.2M | $73.2M | $122.2M |
| Total liabilities | $20.1M | $1.3M | $5.9M | $11.4M | $5.0M |
| Shareholders' equity | $240.4M | $15.8M | $32.3M | $61.8M | $117.2M |
| Ratios | |||||
| Return on assets | -80.5% | -125.1% | -100.3% | -84.2% | -42.3% |
| Return on equity | -87.3% | -135.4% | -118.6% | -99.8% | -44.1% |
| Current ratio | 12.98 | 14.07 | 6.31 | 5.75 | 24.23 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 1,193,708 | $30.9M |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 7.04 (safe)
- Working capital / assets 0.923
- Retained earnings / assets -1.871
- EBIT / assets -0.809
- Equity / liabilities 11.931
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001800315 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.